Vasoactive intestinal polypeptide in cerebrospinal fluid of patients with dementia

References

• Adams R D, Fisher C M, Hakim S, Ojemann R G, Sweet W H. Symptomatic occult hydrocephalus with normal cerebrospinal fluid pressure. New England Journal of Medicine 1965; 273: 117–126
   PubMed Web of Science ®Google Scholar
• Andersen O, Fahrenkrug J, Wikkelso C, Johansson B B. VIP in cerebrospinal fluid of patients with multiple sclerosis. Peptides 1984; 5: 435–437
   Google Scholar
• Edvinsson L, Fahrenkrug J, Hanko J, Owman C, Sundler F, Uddman R. VIP (vasoactive intestinal polypeptide)-containing nerves of intracranial arteries in mammals. Cell Tissue Research 1980; 208: 135–142
   Google Scholar
• Emson P C, Fahrenkrug J, de Muckadell Schaffalitzky O B, Jessel T M, Iversen L L. Vasoactive intestinal polypeptide (VIP): vesicular localization and potassium evoked release from rat hypothalamus. Brain Research 1978; 140: 174–178
   Google Scholar
• Emson P C, Fahrenkrug J, Spokes E GS. Vasoactive intestinal polypeptide (VIP): distribution in normal human brain and in Huntington's disease. Brain Research 1979; 173: 174–178
   Google Scholar
• Fahrenkrug J, Schaffalitzky de Muckadell O B, Fahrenkrug A. Vasoactive intestinal polypeptide (VIP) in human cerebrospinal fluid. Brain Research 1977; 124: 581–584
   PubMed Web of Science ®Google Scholar
• Fahrenkrug J, Schaffalitzky de Muckadell O B. Distribution of vasoactive intestinal polypeptide in the porcine central nervous system. Journal of Neurochemistry 1978; 31: 1445–1452
   PubMed Web of Science ®Google Scholar
• Fahrenkrug J. Vasoactive intestinal polypeptide: measurement, distribution and putative neurotransmitter function. Digestion 1979; 19: 149–169
   PubMed Web of Science ®Google Scholar
• Fahrenkrug J. Vasoactive intestinal polypeptide. Trends Neuroscience 1980; 3: 1–2
   Web of Science ®Google Scholar
• Fuxe K, Hokfelt T, Said S I, Mutt V. Vasoactive intestinal polypeptide and the nervous system: immunohistochemical evidence for localization in central and peripheral neurons particularly intracortical neurons of the cerebral cortex. Neuroscience Letters 1977; 5: 241–246
   PubMed Web of Science ®Google Scholar
• Giachetti A, Said S I, Reynolds R C, Koniges F C. Vasoactive intestinal polypeptide in brain Localization in and release from isolated nerve terminals. Proceedings of the National Academy of Sciences of the United States of America (Washington) 1977; 74: 3424–3428
   Google Scholar
• Hachinski V C, Iliff L D, Zilhka E, Du Boulay G H, Mc Allister V I, Marshall J, Ross Russell R W, Symon L. Cerebral blood flow in dementia. Archives of Neurology 1975; 32: 632–637
   PubMed Web of Science ®Google Scholar
• Harrison M JG, Thomas D J, Du Boulay G H, Marshall J. Multiinfarct dementia. Journal of Neurological Sciences 1979; 40: 97–103
   PubMed Web of Science ®Google Scholar
• Huckmann M S. Normal pressure hydrocephalus: Evaluation of diagnostic and prognostic tests. American Journal of Neuroradiology 1981; 2: 385–395
   Google Scholar
• Johansson B B, Roos B E. Concentration of monoamine metabolites in human lumbar and cisternal cerebrospinal fluid. Acta Neurologica Scandina-vica 1975; 52: 137–144
   Google Scholar
• Johansson B B, Fahrenkrug J, Wikkelsø C, Andersen O, Blomstrand C. Vasoactive intestinal polypeptide in human cerebrospinal fluid. The Cerebrospinal Fluid and Peptide Hormones. Frontiers of Hormone Research, T JB van Wimersma Greidanus. Karger S., Basel 1982; vol 9: 189–197
   Google Scholar
• Johansson B B, Ben-Menachem E, Ekberg K, Wikkelsø C, Fahrenkrug J. Vasoactive intestinal polypeptide (VIP) in cerebrospinal fluid from men after long-term exposure to organic solvents. Acta Neurologica Scandinavica 1984; 70: 317–318
   Google Scholar
• Larsson L-I, Edvinsson L, Fahrenkrug J, Hakansson R, Owman C H, Schaffalitzky de Muchadell O, Sundler F. Immunohistochemical localization of a vaso-dilatory polypeptide (VIP) in cerebrovascular nerves. Brain Research 1976; 113: 400–404
   PubMedGoogle Scholar
• Laurell C-B. Quantitative estimation of proteins by electrophoresis in agarose gel containing entibodies. Analytical Biochemistry 1966; 15: 45–52
   PubMed Web of Science ®Google Scholar
• Lindvall M, Alumets J, Edvinsson L, Fahrenkrug J, Hakansson R, Hanko J, Owman C H, Schaffalitzky de Muckadell O B, Sundler F. Peptidergic (VIP) nerves in the mammalian choroid plexus. Neuroscience Letters 1978; 9: 77–82
   PubMed Web of Science ®Google Scholar
• Loren I, Emson P C, Fahrenkrug J, Björklund A, Alumets J, Håkansson R, Sundler F. Distribution of vasoactive intestinal polypeptide in the porcine central nervous system. Journal of Neurochemistry 1979; 31: 1445–1452
   Google Scholar
• Lowry O H, Rosebrough N I, Farr A L, Randall R J. Protein measurement with the folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Ottesen B, Andersen A N, Gerstenberg T, Ulrichsen H, Manthorpe T, Fahrenkrug J. VIP stimulates prolactin release in women. Lancet 1981; ii: 696
   Google Scholar
• Rossor M, Fahrenkrug J, Emson P, Mountjoy C, Iversen L, Roth M. Reduced cortical choline acetyltransferase activity in senile dementia of Alzheimer type is not accompanied by changes in vasoactive intestinal polypeptide. Brain Research 1980; 201: 249–253
   PubMed Web of Science ®Google Scholar
• Wikkelsø C, Andersson H, Lindberg S, Blomstrand C. Shuntography - a radionuclide scanning method for evaluation of cerebrospinal fluid shunt patency. Nuclear Medicine Com 1983; 4: 88–93
   Google Scholar
• Wikkelsø C, Ekberg K, Lillienberg L, Wetterholm B, Karlsson B, Blomstrand C, Johansson B B. Cerebrospinal fluid proteins and cells in man subjected to long-term exposure to organic solvents. Acta Neurologica Scandinavica 1984; 70: 113–119, 100, suppl
   Google Scholar
• Wikkelsø C, Fahrenkrug J, Blomstrand C, Johansson B B. Dementia of different etiologies: Vasoactive intestinal polypeptide in CSF. Neurology 1985, in press
   Google Scholar